These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. Sandrasegaran K, Tahir B, Nutakki K, Akisik FM, Bodanapally U, Tann M, Chalasani N. AJR Am J Roentgenol; 2013 Dec; 201(6):1211-9. PubMed ID: 24261359 [Abstract] [Full Text] [Related]
5. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T. Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092 [Abstract] [Full Text] [Related]
6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [Abstract] [Full Text] [Related]
14. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T. Dong Y, Liu Q. J Comput Assist Tomogr; 2012 May; 36(4):361-6. PubMed ID: 22805661 [Abstract] [Full Text] [Related]